Cargando…
2170. Association Between End-of-Treatment Procalcitonin Levels with Mortality & Recurrent Ventilator-Associated Pneumonia
BACKGROUND: In the only randomized controlled trial utilizing procalcitonin in ventilator-associated pneumonia (VAP), 30% of patients failed to normalize procalcitonin levels by the end of treatment, a finding of uncertain clinical importance. The prognostic value of procalcitonin for VAP mortality...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752940/ http://dx.doi.org/10.1093/ofid/ofac492.1790 |